Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerance, Pharmacokinetics and Antiviral Activity of Amdoxovir and Zidovudine in Untreated HIV-1 Infected Subjects Currently Untreated

NCT00432016 is registered in ClinicalTrials.gov with RFS Pharma, LLC as lead sponsor.

NCT NCT00432016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00432016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerance, Pharmacokinetics and Antiviral Activity of Amdoxovir and Zidovudine in Untreated HIV-1 Infected Subjects Currently Untreated
Lead sponsor
RFS Pharma, LLC
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2007
Completion date
May 31, 2007
Enrollment
24
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections